Theme
Radiopharmaceuticals
Targeted radioligand therapy and diagnostics.
Radiopharmaceuticals pair targeting molecules with radioactive isotopes to deliver therapy or imaging directly to disease sites. The category combines therapeutic radioligands with companion diagnostics across a constrained isotope supply chain.
Companies · 4
Novartis AGNVS
Market cap$271B
Conviction5 / 5
RadiopharmaceuticalsRNA therapeutics
Read profileLantheus Holdings, Inc.LNTH
Market cap$6.5B
Conviction4 / 5
Radiopharmaceuticals
Read profileTelix Pharmaceuticals LimitedTLX
Market cap$3.8B
Conviction4 / 5
Radiopharmaceuticals
Read profilePerspective Therapeutics, Inc.CATX
Market cap$299M
Conviction3 / 5
Radiopharmaceuticals
Read profile